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 ABSTRACT Nitric oxide associated -1 (NOA1) is an evolutionarily conserved guanosine triphos-
phate (GTP) binding protein that localizes predominantly to mitochondria in mammalian cells. 
On the basis of bioinformatic analysis, we predicted its possible involvement in ribosomal 
biogenesis, although this had not been supported by any experimental evidence. Here we 
determine NOA1 function through generation of knockout mice and in vitro assays. NOA1-
defi cient mice exhibit midgestation lethality associated with a severe developmental defect 
of the embryo and trophoblast. Primary embryonic fi broblasts isolated from NOA1 knockout 
embryos show defi cient mitochondrial protein synthesis and a global defect of oxidative 
phosphorylation (OXPHOS). Additionally,  Noa1–/– cells are impaired in staurosporine-induced 
apoptosis. The analysis of mitochondrial ribosomal subunits from  Noa1–/– cells by sucrose 
gradient centrifugation and Western blotting showed anomalous sedimentation, consistent 
with a defect in mitochondrial ribosome assembly. Furthermore, in vitro experiments revealed 
that intrinsic NOA1 GTPase activity was stimulated by bacterial ribosomal constituents. Taken 
together, our data show that NOA1 is required for mitochondrial protein synthesis, likely due 
to its yet unidentifi ed role in mitoribosomal biogenesis. Thus, NOA1 is required for such basal 
mitochondrial functions as adenosine triphosphate (ATP) synthesis and apoptosis. 
 INTRODUCTION 
 Mitochondria are the principal energy-producing organelles be-
lieved to have evolved from eubacteria that were engulfed by 
primordial eukaryotic cells ( Gray  et al. , 2001 ). In the course of evo-
lution mitochondria retained rudimentary genomes, whereas most 
of the other necessary genetic information was relocated to the 
nucleus of the host cell. As a result, in mammalian cells only 
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13 proteins (all of which are translated by mitochondrial and not 
cytosolic ribosomes) are encoded by mitochondrial DNA (mtDNA). 
Mitochondrial ribosomes (mitoribosomes) are assembled from 
more than 70 nuclearly encoded proteins (at least 29 in the 28S 
small subunit and 48 in the 39S large subunit) and 2 species of 
mitochondrially encoded rRNA  (Koc  et al. , 2001 ). Relatively little is 
known about how these multiple components assemble into a 
catalytically active complex and what factors are required for com-
pletion of this process. We identifi ed nitric oxide-associated -1 
(NOA1) as a predominantly mitochondrially localized guanosine 
triphosphate (GTP) binding protein, homologous to the essential 
 Bacillus subtilis GTPase, YqeH ( Zemojtel  et al. , 2006b ). YqeH de-
fi nes a subfamily of circularly permutated GTPases conserved in 
some species of bacteria and all known eukaryotic organisms ( Leipe 
 et al. , 2002 ). The protein belongs to a larger family of YlqF/YawG 
translation factors (TRAFAC), whose members, such as YlqF, have 
been implicated in ribosomal assembly in  B. subtilis ( Kim do  et al. , 
2008 ). Independent of homology to bacterial YqeH, a possible in-
volvement of NOA1 in mitoribosome function has been implicated 
by data from the yeast protein interactome ( Zemojtel  et al. , 2006a ). 
Here the NOA1 yeast homologue YOR205C was shown to be a 
part of a protein complex associated with the S5 protein of the 
small mitoribosomal subunit. YqeH has been suggested to partici-
pate in the biogenesis of the 30S ribosomal subunit and to assist in 
50S ribosomal subunit assembly ( Loh  et al. , 2007 ;  Uicker  et al. , 
2007 ). In a recent study, human NOA1 was shown to interact with 
complex I of the electron transport chain and with three mitoribo-
somal proteins, MRPL12, MRPS27, and MRPS29 (also known as 
death-associated protein 3 [DAP3]), indicating that NOA1 may in-
teract with the mitoribosome ( Tang  et al. , 2009 ). To date, however, 
no experimental data were available to support a role for NOA1 in 
mitochondrial protein synthesis. Similarly, a physiological role of 
the protein in mammalian development was also unknown. Here 
we present a comprehensive analysis of the cellular and develop-
mental role of mammalian NOA1. We show that NOA1 inactivation 
impairs mitochondrial protein synthesis and causes global defect 
of oxidative phosphorylation (OXPHOS), defective apoptosis, and 
midgestation lethality of knockout mice. 
 RESULTS 
 Noa1 gene inactivation results in midgestation lethality 
 To experimentally address the function of NOA1 in a physiological 
in vivo context, we generated mice in which  Noa1 was inactivated 
( Figure 1 ). Mutant embryos appeared growth retarded and at E9.5 a 
maximum of nine somites was observed ( Figure 1, E–G , and 
 Figure 2A ). At E10.5 many embryos were necrotic, and no viable 
 Noa1–/– embryos were detected thereafter, indicating midgestation 
lethality ( Table 1 ). Cell proliferation as measured by bromodeoxyuri-
dine (BrdU) incorporation was drastically reduced in E9.5  Noa1 –/– 
embryos ( Figure 2A ), and few areas of apoptotic cell death were 
observed ( Figure 2, B and C ), indicating that cell proliferation as well 
as apoptosis was severely impaired. Transmission electron micros-
copy (TEM) of  Noa1 –/– embryos revealed abnormal mitochondria 
with characteristically swollen cristae ( Figure 2D ) but no abnormali-
ties in other organelles. In addition, we observed severe defects of 
the placenta with a reduction of all three trophoblast layers, includ-
ing the trophoblast giant cell (TGC) layer ( Figure 3 , Supplemental 
Figure S1). This fi nding was in line with  Noa1 being expressed in the 
trophoblast but not in the maternal part of the placenta ( Figure 3A ). 
Together these results indicated that  Noa1 is indispensable for nor-
mal development of the embryo and the placenta possibly due to 
an important function in mitochondria. 
 FIGURE 1:  Generation of the  Noa1 knockout mice. (A) Strategy of 
 Noa1 gene targeting. The top bar indicates the enzymatic cleavage 
sites at the  Noa1 genomic locus ( BamH I), K ( Kpn I), N ( Not I), and 
C ( Cla I). GTPase domain encoding Exon1 (dark grey segment) was 
targeted. Homologous recombination using this construct (middle 
bar) resulted in a targeted allele (bottom bar) where a large part of 
exon1 was replaced by the  loxP fl anked, PGK-gb2 promoter driven, 
neomycin/kanamycin resistance cassette (white segment – Neo/Kan; 
yellow triangles –  loxP sites). Insertion of the selection cassette 
introduced a  Not I endonuclease recognition site enabling Southern 
blot–based detection of homologous recombination with the internal 
and external probes (black boxes above the panels). Red rulers 
indicate expected  Bam HI/ Not I fragment sizes for the wild-type locus 
as well as the altered fragment size in the homologously targeted 
locus. Black rulers indicate lengths of the long-range PCR products 
obtained from the wild type and homologously targeted locus. 
(B) Southern blot and long-range-PCR–based detection of the 
homologous recombination. (C) PCR-based genotyping strategy. 
(D) Western blot analyses of E9.5 wild type,  Noa+/– , and  Noa1–/– 
embryo lysates with β-actin as loading control. (E) Appearance of 
 Noa1 knockout embryos at E7.5. (F) A comparison of the intact 
embryos at E9.5 is shown to illustrate the difference in size. (G)  Noa1 
knockout embryo development is arrested at prerotation stage 
(inset). E9.5 wild-type embryo displays 21 somites whereas NOA1-
defi cient littermate (magnifi ed) reaches maximally a 9-somite stage. 
See also Supplemental Movies S1 and S2 available online. 
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Stage Litters Noa1+/+ Noa1+/− Noa1−/− Total
E7.5 2 2 (10%) 13 (65%) 5 (25%) 20
E8.5 7 14 (25%) 32 (58%) 9 (16%) 55
E9.5 16 21 (17%) 80 (66%) 20 (17.0%) 121
E10.5 5 6 (17%) 22 (61%) 8 (22%) 36
E14.5 1 2 (33.3%) 4 (66.6%) 0 6
E15.5 6 16 (31%) 36 (69%) 0 52
E16.5 2 5 (33.3%) 10 (66.6%) 0 15
P1 5 9 (25%) 27 (75%) 0 36
P28 11 32 (38%) 52 (62%) 0 84
 TABLE 1:  Intercross of  Noa1+/ − mice – offspring genotype distribution.  Knockout embryos could not be detected 
beyond E10.5, indicating midgestation lethality. Heterozygous animals were born in the expected Mendelian ratio. No 
overt lethality of heterozygotes was observed in the postnatal period. 
from E9.5  Noa1 –/– embryos.  Noa1- defi cient cells grew in a me-
dium known to compensate for mitochondrial respiratory defi -
ciency and showed no overt abnormalities in the mitochondrial 
network (Supplemental Figure S3A). To test mitochondrial func-
tion we measured cellular respiration by polarographic assays in 
digitonin-permeabilized cells. Complex I–, III–, and IV–dependent 
oxygen consumption was severely reduced in mutant cells 
( Figure 4A ), indicating a global OXPHOS defect. Consequently, 
 Noa1 knockout cells showed reduced viability and cellular ATP 
content when grown under nutrient restriction ( Figure 4, B and C ). 
Similar results were obtained after  NOA1 depletion in HeLa cells 
(Supplemental Figure S2). 
 Because the results of polarographic measurements are 
infl uenced by mitochondrial substrate import, we further ad-
dressed OXPHOS complex function in direct biochemical as-
says. Spectroscopic assays revealed that the activity of complexes 
I, III, IV, and V was strongly reduced in  Noa1–/– cells, whereas the 
activity of complex II was increased ( Figure 4D ). Blue-native electro-
phoresis of isolated mitochondria showed a decreased amount of 
assembled complex I, III, IV, and V ( Figure 4E ) and an accumulation 
of the unassembled complex V (F1), whereas no free F1 subunit was 
detected in wild-type cells. Confi rmatory to this, in-gel activity of 
complex I measured by the colorimetric enzymatic assay (immuno-
globulin E [IgE] ) was also strongly reduced ( Figure 4E , top stripe). 
These fi ndings suggested a general defect of mitochondrial protein 
synthesis in  Noa1–/– cells, as complex I, III, IV, and V all include pro-
teins encoded by the mtDNA, whereas all proteins of complex II are 
encoded in the nucleus and imported into the mitochondrium. 
 Compromised mitochondrial protein synthesis 
in Noa1–/– cells 
 To test this possibility,  Noa1–/– cells were assayed for mitochondrial 
protein synthesis. Radioactive methionine labeling showed a defi -
ciency in de novo mitochondrial protein synthesis ( Figure 5A ). 
Normal copy number and integrity of mtDNA were confi rmed by 
quantitative PCR (qPCR) and long-range PCR, excluding defects of 
replication and/or mtDNA repair as a cause of compromised protein 
synthesis (Supplemental Figure S3, B and C). Expression of genes 
encoding proteins of the electron transport chain or mitoribosomal 
function was increased in the mutant cells, indicating that mtDNA 
transcription in the knockout cells was maintained, increased ex-
pression likely being compensatory to the protein synthesis defect 
( Figure 5B ). Interestingly, 16S rRNA transcript level from the large 
ribosomal subunit was increased twofold in mutant cells whereas 
12S rRNA remained at the control level indicative of a possible de-
fect of mitoribosome biogenesis ( Uicker  et al. , 2007 ). These results 
are consistent with NOA1 being required for mitochondrial protein 
synthesis. 
 FIGURE 2:  Phenotype of  Noa1 knockout mice. (A) BrdU in-vivo label-
ing reveals arrest of proliferation in the E9.5  Noa–/– embryos. (B and C) 
Apoptosis in the E9.5  Noa1–/– embryos visualized by anti-activated 
caspase-3 immunolabeling in the whole mount preparations (B) and 
TUNEL staining on paraffi n sections (C). Data are representative of at 
least three embryos analyzed for each genotype. (D) Electron micro-
scopic analysis of the  Noa1–/– embryos. Many mitochondria show ab-
errant morphology characterized by swollen intracristal spaces (single-
headed arrows). Some appear collapsed into electron dense, shrunken 
remnants (double-headed arrow). Endoplasmic reticulum and other or-
ganelles appear normal in  Noa1–/– embryos (data not shown). ba – 
branchial arche, h – heart, nt – neural tube. 
 Global OXPHOS defect in the  Noa1–/– cells 
 To gain further information on the biochemical consequences 
of  Noa1 inactivation we isolated primary embryonic fi broblasts 
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more, although  Noa1 defi ciency had only 
a minimal effect on the position or band 
intensity of the small subunit in the su-
crose gradient ( Figure 4C , bottom pan-
els), the large subunits showed a marked 
shift to the slower migrating particles 
(lane 5, NOA1–/–  cf. NOA1+/+); these ef-
fects were rescued by adding  Noa1 in 
trans (NOA1–/– comp. in  Figure 5C ). 
Additionally, NOA1 complementation led 
to increased abundance of L12 protein in 
fractions 9 and 10. In line with the ob-
served partial rescue of mitoribosomal 
assembly, retroviral complementation re-
sulted in reactivation of mitochondrial 
protein synthesis, normalization of respi-
ratory chain complex assembly, and im-
proved viability of the knockout cells 
(Supplemental Figure S4). These data 
strongly suggest that inactivation of  Noa1 
resulted in an impaired assembly of the 
55S mitoribosome. 
 The GTPase activities of mammalian 
NOA1 and its bacterial homologue 
YqeH are stimulated by ribosomal 
components from  Escherichia coli 
 To gain further insight into NOA1 func-
tion, we purifi ed mammalian NOA1 as 
well as its bacterial homologue YqeH from 
 B. subtilis . Both mitochondrial NOA1 and 
bacterial YqeH showed a high and com-
parably strong intrinsic GTPase activity 
( Figure 6A ). This observation was not 
made with other G-factors involved in 
translation, such as elongation factor G 
(EF-G), which can be stimulated exclu-
sively by 70S ribosomes during protein 
synthesis and is boosted by empty 
70S uncoupled from protein synthesis 
(Gordon,  1970 ;  Qin  et al. , 2006 ). In line 
with a previously proposed role in 30S as-
sembly, YqeH GTPase activity could be 
stimulated by  E. coli 16S rRNA, more than 
twofold, whereas the addition of 23S 
rRNA had no effect ( Figure 6B ), similar to poly(U) addition (data 
not shown). 
 In addition, 21S precursor particles of the 30S subunit stimu-
lated the YqeH GTPase activity rather than mature 30S and 50S 
subunits or 70S ribosomes ( Figure 6C ). In contrast, NOA1 activity 
was stimulated by rRNAs of the small and large ribosomal subunits 
from both mammalian (human) mitochondria (12S and 16S rRNAs) 
and  E. coli (16S and 23S rRNAs) by 40% ( Figure 6D ). Precursor of 
the 30S  E. coli ribosome, the 21S particle prepared by total recon-
stitution (Nierhaus,  1990 ), stimulated NOA1 activity with approxi-
mately the same intensity ( Figure 6E ). Total reconstituted 30S par-
ticles as well as native 30S subunits induced a striking twofold 
increase of GTPase activity. Interestingly, the strongest effect was 
observed with 50S particles, whereas 70S ribosomes showed four 
times less stimulation underlining the specifi city of the observed 
effects. These results suggest an involvement of both bacterial 
YqeH and mammalian NOA1 in ribosomal biogenesis. 
 Altered mitoribosomal profi le in the  Noa1–/– cells 
 Protein synthesis within mitochondria is performed by 55S mito-
ribosomes, each of which consists of a small 28S subunit and a 
large 39S subunit. To determine whether the observed mito-
chondrial protein synthesis defect was due to a ribosomal dys-
function, we compared the mitoribosome sucrose density pro-
fi les of wild type or rescued cells and those lacking  Noa1 . The 
small subunit was traced with antibodies against the mitochon-
drial protein S18b (MRPS18b), which consistently revealed a 
similar profi le between wild type (NOA1+/+) and knockout cells 
(NOA1–/–). Similar levels of the 28S small subunit were found in 
fractions 4 and 5 in the wild type, knockout (NOA1–/–), and com-
plemented cells (NOA1–/– Comp.), but no 55S ribosomes could 
be visualized ( Figure 5C , fractions 8–10). Antibodies against the 
mitochondrial protein L12 (MRPL12), which reacted with the 
large 39S subunit (fractions 6 and 7), revealed the decrease in 
55S ribosomes in the NOA1–/– cell line (fractions 8–10). Further-
 FIGURE 3:  Noa1 is indispensable for placental trophoblast development. In situ hybridization 
on the sections of E8.5, E9.5, and E10.5 wild type and mutant littermate embryos at the 
implantation sites. Boxed areas in the top panels are enlarged in bottom panels. (A)  Noa1 
expression is restricted to the placental trophoblast at E9.5 (arrow). Intense expression in the 
labyrinth and spongiotrophoblast (arrowheads – magnifi cation 1×) and in the trophoblast giant 
cells (arrows – magnifi cation 2×).  Noa1 expression could not be detected in the maternal part of 
the placenta (star) or in the knockout embryos (data not shown). (B) Defect of the trophoblast 
progenitor cell differentiation in the  Noa1–/– mice. 4311/Tbpb is expressed in the trophoblast 
progenitor cells which give rise to glycogen cells and secondary giant trophoblast cells. 
Diminished 4311/Tbpb expression in the E8.5, E9.5 ectoplacental cone. (C) Defect of 
trophoblast giant cell differentiation in E9.5 and 10.5  Noa1–/– embryos visualized by diminished 
expression of placental lactogen I (PLI ). 
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restored caspase-3 activation in  Noa1–/– 
cells (Supplemental Figure S4E). Addition-
ally, mitochondrial membrane potential de-
termined with JC-1 staining was increased in 
knockout cells corroborating the observed 
apoptosis defect (Supplemental Figure S4F). 
Thus, NOA1 is necessary for activation of 
caspase-dependent apoptosis. 
 DISCUSSION 
 In the current study we address both the 
cellular and the developmental function of 
NOA1 by inactivating the gene in mice. The 
vital role of  Noa1 was underlined by a mas-
sively restricted growth and arrested prolif-
eration at ∼E9.5 followed by the death of 
 Noa1–/– mice at ∼E10.5 ( Table 1 and 
 Figures 1 and  2A ). The mitochondria in 
these developing embryos showed aberra-
tions of cristae morphology, whereas other 
organelles appeared not to be affected 
( Figure 2D ). Thus, both the timing of the 
lethality as well as the results of electron mi-
croscopic analysis refl ect the important mi-
tochondrial function of NOA1. Interestingly, 
the developmental defect extended to the 
placental trophoblast, which constitutes 
the interface between maternal and em-
bryonic circulation ( Figure 3B , Supplemen-
tal Figure 1)  (Red-Horse  et al. , 2004 ). The 
defect occurs at a relatively early stage of 
trophoblast differentiation as revealed by 
the diminished expression of 4311/Tbpb, 
demarcating the population of trophoblast 
progenitor cells at E8.5. The dependence of 
trophoblast development on NOA1 func-
tion exposes a crucial role of mitochondria 
in the development of the maternal–fetal 
interface. The importance of mitochondrial 
function in this process is further supported 
by the observation that knockouts of mito-
chondrial fusion factor Mtf2 as well as of 
mito-division factor Drp1 result in a defi -
ciency of trophoblast giant cells ( Chen  et al. , 
2003 ;  Wakabayashi  et al. , 2009 ). 
 The nature of NOA1 mitochondrial func-
tion was investigated in primary knockout 
mouse embryonic fi broblast (MEF) cells. 
 Noa1–/– cells were shown to have impaired 
activities of the electron transfer chain com-
plexes I, III, IV, and V but not of complex II, 
which lends strong support to NOA1 being 
required for expression of the mitochondrial genome. We therefore 
analyzed all stages of mtDNA expression and determined that 
NOA1 defi ciency impairs protein synthesis but does not cause loss 
of mtDNA and/or transcription. Thus, NOA1 appears to be specifi -
cally required for mitochondrial protein synthesis. Sucrose gradient 
centrifugation and Western blot experiments revealed that knock-
out cells exhibit an aberrant migration of the large mitoribosomal 
subunit, indicating that NOA1 is required for correct mitoribosome 
assembly ( Figure 5D ). Involvement of NOA1 in the biogenesis of 
the small mitoribosomal subunit cannot be ruled out at present, 
 Noa1–/– cells are resistant to staurosporine-induced 
apoptosis 
 NOA1 was previously reported to be involved in regulation of apop-
tosis in HeLa cells ( Tang  et al. , 2009 ). To verify whether the mitochon-
drial defects in NOA1-defi cient cells would also be accompanied by 
the impairment of apoptosis, embryonic fi broblasts were treated with 
staurosporine and apoptosis was monitored by accumulation of the 
cleaved caspase-3. A robust caspase-3 activation was detected 24 h 
postinduction in the control cells but was entirely absent in the mutant 
cells ( Figure 7 ). Retroviral reconstitution of NOA1 expression partially 
 FIGURE 4:  OXPHOS defi ciency in  Noa1–/– cells. (A) Cells were permeabilized with digitonin, and 
oxygen consumption was monitored polarographically in the presence of respiratory chain 
substrates and inhibitors. Note a marked decrease of the complex I–, III–, and IV–dependent 
oxygen consumption but not complex II–dependent oxygen consumption. Results represent 
mean ± SD of three independent experiments. (B) Reduced viability of the NOA1-defi cient cells 
was determined with Alamarblue. (C)  Noa1–/– cells show reduced ATP levels upon glucose 
deprivation. See also Supplemental Figure S6 for genetic complementation data. (D) Reduced 
enzymatic activities of the mitochondrial complexes I, III, IV, and V in the knockout cells. In 
contrast, complex II activity was increased. The enzymatic assay values are shown standardized to 
CS E3 activity. Results represent mean ± SD of three independent experiments. (E) In-gel activity 
(IGA) of complex I is decreased in knockout cells. Blue native electrophoresis (BN) showing 
reduction in quantities of the assembled complexes I, III, IV, and V and accumulation of the 
unassembled complex V intermediate (F1) in the homozygous  Noa1 mutant cells. 
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reconstitution intermediate of the small subunit, which is highly 
similar to the native 21S precursor particle (for a review, see 
Nierhaus,  1991 ). The strong stimulation contrasts with the effects of 
23S rRNA and the mature ribosomal subunits, which did not stimu-
late the intrinsic activity of YqeH. This fi nding supports the notion 
that the major activity of the bacterial YqeH is related to the early 
assembly phase of the small subunit. Interestingly, mammalian 
NOA1 was stimulated both by the bacterial 50S large ribosomal 
subunit and by the 30S small subunit. To a lesser degree, NOA1 
was also stimulated by naked rRNAs and precursor 21S particles, 
whereas only residual stimulation was observed with full 70S ribo-
somes. These data show that NOA1, like its bacterial homologue 
YqeH, has GTPase activity that is stimulated by the bacterial ribo-
somal constituents. The apparent difference in NOA1 and YqeH 
specifi city likely refl ects their evolutionary divergence. Indeed, 
NOA1 contains an ∼100-amino-acid insertion in the GTP-binding 
domain, which is absent from bacterial YqeH and  Arabidopsis 
NOA1 proteins. The latter could explain the differences in protein 
however. In this study our choice of antibodies against mouse small 
mitoribosomal subunit was limited to anti-MRPS18b, which did not 
show any defect. Several other commercially available anti-MRP an-
tibodies were tested, but none were capable of cross-reactivity with 
murine MRPs (data not shown). 
 Our knowledge about mitochondrial ribosome biogenesis and 
function is essentially based on the studies of bacterial and yeast 
model systems. Ribosome assembly comprises the processing and 
folding of pre-RNA and its concomitant assembly with ribosomal 
proteins. A large number of ribosomal constituents as well as non-
ribosomal factors are involved. Among these factors, the GTPases 
(a family of energy-consuming enzymes characterized by the so-
called G-domain) have been shown to play key roles in the assem-
bly of ribosomes in bacteria (Karbstein,  2007 ; Britton,  2009 ). As 
shown here, mitochondrial NOA1, similarly to its bacterial homo-
logue YqeH, has GTPase activity. The intrinsic GTPase activity of 
the  B. subtilis YqeH is strongly and specifi cally stimulated by 
16S rRNA of the small subunit from  E. coli as well as by the 21S 
 FIGURE 5:  NOA1 defi ciency impairs mitochondrial protein synthesis. (A) [ 35 S]methionine labeling of mitochondrial 
protein synthesis in primary embryonic fi broblasts reveals defi cient translation in NOA1 knockout cells. Concentrations 
of protein lysates were calculated by the bicinchoninic acid (BCA) method, and equal loading was confi rmed by 
Coomassie staining following exposure (data not shown). (B) Real-time PCR quantifi cation of the mitochondrial gene 
transcript levels. RNA species encoded by mitochondrial (underlined red) and nuclear (underlined blue) DNA were 
quantifi ed. Data were normalized against glyceraldehyde-3-phosphate dehydrogenase (GAPDH) and actin expression. 
(C) Cell lysates were fractionated in the 10–30% (vol/vol) isokinetic sucrose gradients and analyzed by Western blots 
with antibodies against MRPL12 (39S mitoribosomal subunit) or MRPS18b (28S mitoribosomal subunit). Representative 
blots were analyzed densitometrically (bottom panel). See also Supplemental Figure S4 for genetic complementation 
data. comp. – knockout cells with retroviral complementation of NOA1 expression. 
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lated from the knockout embryos were impaired in staurosporine-
induced apoptosis ( Figure 7A ), and retroviral complementation 
partially reversed this phenotype (Supplemental Figure S4E). 
Importantly, NOA1 inactivation results in hyperpolarization of mito-
chondria, which likely contributes to the phenotype of defective 
apoptosis (Supplemental Figure S4F). In line with that, NOA1 knock-
down in neuroblastoma cells was reported to result in mitochondrial 
hyperpolarization, preventing cytochrome  c release ( Parihar  et al. , 
2008 ). Thus, although the exact molecular mechanism remains to 
be discovered, it is increasingly clear that a group of mitoribosome-
associated proteins, including NOA1, is required for the execution 
of programmed cell death. 
 Interestingly, NOA1 appears to play a similar role in plants, as 
 Arabidopsis NOA1 (formerly atNOS1 [Arabidopsis thaliana nitric 
oxide synthase 1] ) was shown to localize to plastids, where it is 
necessary for protein synthesis ( Flores-Perez  et al. , 2008 ). Simi-
larly, plastidial NOA1 localization was shown in the phytoplank-
ton diatom  Phaeodactylum tricornutum ( Vardi  et al. , 2008 ). Re-
markably, defi cient growth and the greening phenotype of 
atNOA1-defi cient plants could be complemented by  B. subtilis 
YqeH fused to the  Arabidopsis NOA1 organelle localization se-
quence ( Flores-Perez  et al. , 2008 ), clearly demonstrating that 
YqeH is a functional orthologue of plastid-localizing atNOA1. 
Like mitochondria, plastids are believed to have originated from 
target recognition ( Zemojtel  et al. , 2004 ). These data, together with 
the observed aberrant migration of the large ribosomal subunit in 
the  Noa1 knockout cells, further suggest a possible involvement of 
NOA1 in the mitoribosome biogenesis. 
 Several proteins involved in mitochondrial protein synthesis have 
been shown to be involved in the process of apoptosis. Among 
them were mitoribosomal GTP-binding protein MRPS29/DAP3 
(death-associated protein 3), MRPS30/PDCD9 or p52 (programmed 
cell death protein 9), and a protein with an apparent dual cell 
protective as well as pro-apoptotic function PDCD8/AIF (apoptosis-
inducing factor)  (Cavdar Koc  et al. , 2001 ; O’Brien,  2002 ;  Cheung 
 et al. , 2006 ). Interestingly, DAP3 was among several ribosomal pro-
teins recently shown to interact with NOA1 ( Tang  et al. , 2009 ). 
 Similarly to DAP3, NOA1 appears to be necessary for 
mitochondria-dependent apoptosis. The primary fi broblasts iso-
 FIGURE 7:  Noa1 -defi cient cells are resistant to staurosporine -induced 
apoptosis. Embryonic fi broblasts were cultured on coverslips in the 
presence of increasing concentrations of staurosporine. Apoptosis 
was monitored by measuring activation of the caspase-3. (A) The 
caspase-3–positive area was quantifi ed using ImageJ software and 
corrected for the cell number. Representative microscopic pictures are 
shown (data represent mean of at least 10 evaluated images with SEM 
as error bars). (B) Western blot with anti-activated caspase-3 
antibodies. Blots were stripped and probed with the antibody against 
GAPDH for loading control. 
 FIGURE 6:  GTPase activities of NOA1 and YqeH are differently 
stimulated by ribosomal components from  E. coli . (A) Intrinsic GTPase 
activities of NOA1 and YqeH at 30°C. (B) Specifi c stimulation of YqeH 
GTPase activity by  E. coli 16S rRNA at 30°C. (C) Specifi c stimulation of 
YqeH GTPase by equimolar amounts of  E. coli 30S precursors (21S) in 
comparison to total reconstituted 30S subunits (21S+TP30), ribosomal 
subunits (30S, 50S), and 70S ribosomes at 20°C. (D) Stimulation of 
NOA1 GTPase by equimolar amounts of mitochondrial rRNA (mt12S, 
mt16S) and  E. coli rRNA (Ec16S, Ec23S) at 20°C. (E) Stimulation of 
NOA1 GTPase by equimolar amounts of  E. coli 30S precursors before 
(21S) and after total reconstitution of 30S particles (21S+TP30), 
ribosomal subunits (30S, 50S), and 70S ribosomes at 20°C. 
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(Sigma). Cells were processed 18 h later for immunofl uorescence by 
fi xing in 4% PFA and 1× PBS for 10 min and permeabilizing with 
0.4% Triton X-100, 3% BSA, and 1× PBS for 10 min at 4°C. Incuba-
tion with an antibody against activated caspase-3 (Cell Signaling 
Technology) 1:400 was performed overnight in 3% BSA at 4°C. For 
visualization, an anti–rabbit immunoglobulin G (IgG) Alexa Fluor 488 
(Invitrogen, Molecular Probes) conjugate was applied. Nuclei were 
stained with 4’,6-diamidino-2-phenylindole (DAPI), and cells were 
mounted in Fluoromount (Scientifi c Services, Sparrow Bush, NY). 
Cells were photographed using a fl uorescence microscope (BX60; 
Olympus, Center Valley, PA) or scanning microscope (LSM510meta; 
Zeiss, Jena, Germany ). For each treatment, at least 10 images were 
evaluated with ImageJ software. Experiments were repeated at 
least three times, and more than 1,000 cells per sample were 
counted. 
 Immunocytochemistry 
 Cells grown on gelatin-coated coverslips were fi xed with 4% PFA 
and permeabilized in PBS/0.1% Triton X-100. Nonspecifi c binding 
was reduced by blocking with 5% bovine calf serum in PBS, and the 
cells were incubated with primary antibody in 1% BSA/PBS. 
 In situ hybridization 
 Embryos in deciduas were fi xed overnight at 4°C in 4% PFA, dehy-
drated through an ethanol and xylene series, and embedded in par-
affi n blocks. Sections (6 µm) were cut in a transverse plane with re-
spect to the placenta. Slides were processed for hematoxylin–eosin 
staining and in situ hybridization as previously described ( Vortkamp 
 et al. , 1996 ). Riboprobe template vectors were provided by 
Malgorzata Gasperowicz and James Cross, University of Calgary, 
Canada. For genotyping, embryonic tissue was scraped off 
unstained slides. DNA was recovered and genotyped by PCR. 
 HeLa cell culture and small interfering RNA (siRNA) 
transfections 
 HeLa human cervical carcinoma cells were maintained in DMEM 
medium (4.5 g/l glucose) supplemented with 10% fetal calf serum 
(FCS), penicillin G at 100 IU/ml, streptomycin at 100 g/ml, and 2 mM 
L-glutamate and cultured at 37°C in a humidifi ed atmosphere con-
taining 5% CO 2 and 95% air. The sequence of the sense strand of 
the NOA1 targeting siRNA was (GGUCAUACGUUACUCCAGA) 
dTdT. siRNA was transfected using DreamFect (Oz Biosciences, 
Marseille, France). 60% confl uent cells were transfected with 1 µM 
siRNA (20 nmol of double-stranded RNA [dsRNA]) according to sup-
plied protocol. Following transfection, cells were cultured in DMEM 
containing 10% FCS for 3 days. Cells were harvested 72 h post-
transfection for analysis. HeLa cells transfected with scrambled 
siRNA were used as control. 
 Western blotting 
 Protein lysates were prepared in SDS radioimmunoprecipitation 
assay (SDS RIPA) buffer supplemented with a complete protei-
nase tablet (Roche), 1 mM phenylmethylsulfonyl fl uoride (PMSF), 
1 mM sodium vanadate, and 1 mM sodium fl uoride. The lysate 
concentrations were determined using the Bradford assay (Bio-
Rad, Hercules, CA). Lysates (40 µg of protein per well) were re-
solved in 10% SDS–PAGE and subsequently transferred to poly-
vinylidene fl uoride (PVDF) membranes. The blots were probed 
with the rabbit anti-NOA1 polyclonal antibody generated against 
peptide: CVNVKGQRMKKSVAYK (1:100). Other antibodies used 
were: rabbit anti-actin (1:1,000; Sigma). Blots were developed 
with the Western Lightning® Plus–ECL system (PerkinElmer) . 
eubacterial endosymbionts. Thus mammalian NOA1 is an evolu-
tionarily extremely conserved GTPase, required for protein syn-
thesis in prokaryote -derived organelles. Further investigation 
into NOA1 structure and function is needed to unravel the exact 
mechanisms of its function in relation to mitoribosome and apop-
totic action. The  Noa1 inactivation in mouse, however, demon-
strates that this gene product plays a vital role in mitochondrial 
homeostasis and mammalian development. 
 MATERIALS AND METHODS 
 Tissue isolation and processing 
 BrdU solution (10 µl of 10 mM solution/1 g of mouse body weight) 
was injected intraperitoneally into pregnant mice 1 h before the 
mice were killed. Embryos were dissected from deciduas using an 
inverted microscope (Leica, Wetzlar,  Germany). Whole embryos 
were photographed in phosphate-buffered saline (PBS) using a 
microscope-mounted digital camera (Leica, Germany). Embryonic 
stages were estimated by timed pregnancies and somite counts. 
The embryos were fi xed in 4% paraformaldehyde (PFA) pH 7.4, de-
hydrated in ethanol, and paraffi n embedded. The specimens were 
sectioned at 6 µm, stained with hematoxylin–eosin or processed for 
immunohistochemical staining. 
 MEF culture 
 Eviscerated embryos were collected in U-bottomed 96-well plates, 
cut into small fragments with dissection forceps, and digested in 
25-µl of cell culture grade, 0.5% wt/vol trypsin at 37°C for 20 min. 
Subsequently, they were dispersed by pipetting and plated into 
one well of the 96-well, fl at-bottomed plate in 200 µl of fresh DMEM 
containing glucose at 1 g/l, 10% fetal bovine serum (FBS), 2% pen-
icillin/streptomycin, L-uridine at 50 µg/ml (Sigma, St. Louis, MO), 
0.1 mM nonessential amino acids (Invitrogen, Carlsbad, CA), 1 mM 
sodium pyruvate (Sigma), and 10% Amniomax C-100 supplement 
(Invitrogen). The medium was changed every second day until cells 
reached confl uence. Cells were subsequently expanded and con-
tinuously passaged until spontaneously immortalized colonies were 
derived. Cells were cultured at 37°C in 95% air / 5% CO 2 . 
 Retroviral infection 
 BOSC23 packaging cells were transiently transfected with a retro-
viral vector expressing mouse  Noa1 (pQCXIP-mNOA1) using the 
CalPhos Mammalian Transfection Kit (Clontech Laboratories, 
Mountain View, CA ). Retroviral stocks were collected 48 h post-
transfection.  Noa1- defi cient MEFs were infected with the retrovi-
rus in the presence of 6 µg of polybrene and selected for 4 days 
with puromycin at 2.5 µg/ml . 
 Immunofl uorescence 
 For BrdU detection, sections were pretreated by 2N HCl treatment 
and incubated with a monoclonal antibody against BrdU (1:50; 
Roche Diagnostics, Indianapolis, IN ). Apoptotic cell death was visu-
alized in the whole mount specimens with antibodies against acti-
vated caspase-3 (Cell Signaling Technology, Danvers, MA). Terminal 
deoxynucleotidyl transferase dUTP nick end labeling (TUNEL) as-
says on the paraffi n sections were performed using the In Situ Cell 
Death Detection Kit (Roche Diagnostics ) following the manufactur-
er’s protocol. Alexa-568 and/or Alexa-488 conjugated goat anti–
rabbit secondary antibodies were used in all experiments. 
 Quantifi cation of immunofl uorescence staining 
 Embryonic fi broblasts were seeded on coverslips. After 12 h, the 
cells were treated with increasing concentrations of staurosporine 
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 Analysis of mitochondrial protein synthesis 
 In vitro pulse labeling of mitochondrial translation products was 
performed as described elsewhere ( Boulet  et al. , 1992 ), with a 
few adaptations. In brief, cells were labeled for 60 min at 37°C in 
L-methionine–free and L-cysteine–free DMEM with 10% dialyzed 
FCS, [ 35 S]methionine and [ 35 S]cysteine at 200 µCi/ml (Tran35S-
Label; MP Biomedicals, Eindhoven, The Netherlands), and 
emetine at 100 µg/ml, and were subsequently chased for 10 min 
in regular DMEM with 10% FCS. Total cellular protein was resus-
pended and incubated for 10 min in PBS containing 2% lauryl 
maltoside. Unsolubilized material was removed by centrifugation 
at 10,000 ×  g for 10 min. The protein concentration was deter-
mined (Micro BSA Protein Assay Kit; Pierce ) and loading buffer 
was added to the supernatant 1:1 (Tricine Sample Buffer; Thermo 
Fisher Scientifi c, Rockford, IL). The samples were separated 
through 16% polyacrylamide gels and subsequently scanned on 
a FLA5100 (Fujifi lm Life Science, Düsseldorf, Germany). Equal 
protein loading was confi rmed using colloidal Coomassie Blue 
staining (data not shown). 
 Isokinetic sucrose gradient analysis of mitochondrial 
ribosomes 
 Cell lysis was performed in 50 mM Tris-HCl pH 7.4, 150 mM NaCl, 
1 mM EDTA, 1% Triton X-100, + PI-Mix, 1 mM PMSF, and 10 mM 
MgCl 2 for 30 min at 4˚C. After a 10-min incubation, lysate was 
clarifi ed by centrifugation at 12,000 ×  g at 4˚C. Approximately 
0.9 mg of supernatant was loaded onto a linear sucrose gradient 
(10–30% [vol/vol], 1 ml) in 50 mM Tris-HCl, pH 7.2, 10 mM 
Mg(OAc) 2 , 40 mM NH 4 Cl, 100 mM KCl, 1 mM PMSF, and chloram-
phenicol at 50 µg/ml and centrifuged for 2 h 15 min at 100,000 × 
 g at 4˚C. Fractions of 100 µl were collected, and 10 µl of each frac-
tion was analyzed by Western blot. Antibodies used were anti-
MRPS18b (ProteinTech Group, Chicago, IL) and anti-MRPL12 
(Abcam, Cambridge, MA). 
 Quantitative RT–PCR 
 cDNAs were synthesized from 1 µg total RNAs with murine leuke-
mia virus (MuLV) reverse transcriptase (Applied Biosystems, 
Carlsbad, CA). TaqMan universal PCR was then performed on an 
ABI PRISMs 7900 cycler (Applied Biosystems), using the SYBR 
green method according to the manufacturer’s instructions. Tran-
scripts of the following genes were monitored: NOA – NOA1, 16S 
RNA, 12S RNA, ND1 – NADH dehydrogenase subunit 1; ND6 – 
NADH dehydrogenase subunit 6, CytOx1 – Cyt  c oxidase subunit 
1, CytOx2 – Cyt  c oxidase subunit 2, cytB – cytochrome  b , ATP6 – 
ATP synthase F0 subunit 6, EF-Tu – Elongation Factor Tu, L20 – 
mitochondrial ribosomal protein L20, AIF – apoptosis inducing 
factor (see also supplemental primer list). 
 mtDNA analysis 
 The mtDNA/nuclear DNA (mtDNA/nDNA) ratio was estimated us-
ing qPCR with primers specifi c for mtDNA-encoded  Cox1 gene 
(subunit 1 of cytochrome  c oxidase) and nuclearly encoded  Ndufv1 
gene (NADH:ubiquinone oxidoreductase) (see supplemental primer 
list). DNA quantifi cation was repeated fi ve times in independent 
qPCR reactions, and an average mtDNA/nDNA ratio was calculated. 
All values were expressed as means ± SD. 
 Mitochondrial genome integrity was tested using primers listed 
in the supplement and the Expand Long Template PCR System 
(Roche) according to the manufacturer’s protocol. PCR conditions 
were: 94°C for 3 min; 10 cycles: 94°C for 10 s, 65°C for 30 s, 68°C 
for 16 min; 20 cycles: 94°C for 10 s, 65°C for 30 s, 68°C for 16 min 
 TEM 
 Whole E9.5 embryos were fi xed with 2.5% glutaraldehyde in 0.1 M 
cacodylate buffer solution (pH 7.3) at 4°C, washed, and postfi xed in 
2% osmium tetroxide in the same buffer. Samples were dehydrated 
in ethanol, then embedded in Eponate 12 epoxy resin (Serva, 
Heidelberg, Germany) and sectioned on a Reichert-Jung Ultracut 
microtome (Leica, Wetzlar, Germany) . Semithin sagittal sections of 
whole embryos were stained with methylene blue-azure to locate 
and mark the somite regions. The ultrathin sections were prepared, 
stained with uranyl acetate followed by lead citrate, and imaged 
using an EM906 Zeiss (Oberkochen, Germany) electron microscope 
at 80 kV. 
 Optical tomography (OPT ) 
 The OPT method was used to visualize embryos in three dimensions 
(3D). The method accumulates projection images of an entire speci-
men from many different angles, and recalculates the original 3D 
structure by using a “back-projection” reconstruction algorithm 
( Sharpe  et al. , 2002 ). OPT scans were performed in UV light using a 
GFP1 fi lter for detection of the embryos’ autofl uorescence using 
IPLab software from Scanalytics (Rockville, MD). Results were 
exported to QuickTime movies. 
 Polarography 
 MEFs and siRNA-treated HeLa cells were trypsinized, washed 
twice with PBS, and permeabilized with digitonin at 50 µg/ml. The 
optimum incubation time for permeabilization (50 s for MEFs; 
120 s for HeLa) was determined in separate time series for each 
cell line and defi ned as the shortest duration after which 99% of 
the cells were trypan blue positive. Additionally, we verifi ed ade-
quate mitochondrial coupling by measuring the increase of respi-
ration after decoupling with DNP (2,4-dinitrophenol) in compari-
son to the state IV respiration without ADP. The DNP / state IV 
respiration rates were 1.7 ± 0.1 in wild-type cells and 1.8 ± 0.2 in 
the knockout MEF cells. The cells (1 × 10 7 ) were resuspended in 
reaction buffer and introduced into the reaction chamber of a 
Clark-type electrode (Hansatech Instruments, Norfolk, England), 
and oxygen concentrations were measured in 1-ml volumes at 
37°C with substrates and inhibitors according to standard proto-
cols ( Hofhaus  et al. , 1996 ). After completion of the polarographic 
measurement, cells were collected and DNA quantifi ed using a 
Quant-iT PicoGreen DNA kit (Invitrogen) according to the supplied 
protocol. Oxygen consumption was given as mean ± SD nmol O 2 
per minute per µg of DNA ( n ≥ 4). 
 Blue-native PAGE and complex I in-gel activity assay 
 Blue-native PAGE was used for separation of the OXPHOS com-
plexes on 5–15% polyacrylamide-gradient gels as described before 
( Calvaruso  et al. , 2008 ). After electrophoresis of 40 µg of protein 
from MEFs, gels were further processed for in-gel activity assays and 
Western blotting. Assembly of the OXPHOS complexes was ana-
lyzed using monoclonal antibodies against subunits of complex I 
(NDUFA9, NDUFS3), complex III (Core2), complex V (α-ATPase) 
(Molecular Probes, Leiden, The Netherlands), and complexes II 
(SDHA) and IV (CoxVa) (MitoSciences, Eugene, OR). 
 OXPHOS enzyme complex measurements 
 The activities of the OXPHOS enzyme complexes were measured in 
MEFs as described previously (Lazarov and Cooperstein,  1951 ; 
 Smeitink  et al. , 2001 ;  Janssen  et al. , 2003 ,  2007 ). Citrate synthase 
(CS) activities were determined in cultured fi broblast as previously 
described (Srere,  1969 ). 
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subunit (TP30) for 30 min at 40°C in 15 ml of Rec20 buffer: 20 mM 
HEPES-KOH (pH 7.6 at 0°C), 20 mM Mg(acetate) 2 , 400 mM 
NH 4 (acetate), and 4 mM β-mercaptoethanol (for details, see 
Nierhaus,  1990 ). Subsequently, poly(U)-dependent poly(Phe) syn-
thesis was performed with 6 pmol of reconstituted particles, which 
were incubated at 37°C for 1 h in 40 µl with 6 pmol of 50S subunits, 
13.4 µg of bulk transfer RNA (tRNA bulk ), 33.4 µg of poly(U), 10 nmol 
of phenylalanine (23 dpm/pmol), 3.33 µl of S100 enzymes in the 
presence of 20 mM HEPES-KOH (pH 7.6 at 0°C), 6 mM Mg(acetate) 2 , 
150 mM NH 4 (acetate), 4 mM β-mercaptoethanol, 2 mM spermidine, 
0.05 mM spermine, 3 mM ATP, 1.5 mM GTP, and 5 mM acetyl 
phosphate. The reaction mix (35 µl) was subjected to hot trichloro-
acetic acid (TCA) precipitation and fi ltered through glass fi lters. 
Control reconstitutions were performed at 20°C for 1 h, but other-
wise under identical conditions in the presence and absence of 
9 pmol of YqeH. The  B. subtilis YqeH factor did not accelerate the 
 E. coli reconstitution process of the 30S subunit. 
 Preparation of 21S particle 
 600 A 260 units of 16S rRNA and 240 e.u. of TP30 were reconstituted 
for 30 min in ice water. The incubated sample was centrifuged 
through a 10–30% sucrose gradient containing Rec20 in a Beckman 
Zonal rotor at 24,000 rpm for 19 h at 4°C. Fractions containing the 
heavy shoulder of the 21S peak were collected and the particles 
were pelleted and resuspended in Rec20 buffer. Protein content of 
the 21S particles was determined by two-dimensional electrophore-
sis, and the following proteins were detected: S4, S5, S7, S8, S9, 
S13, S14, S15, S16, and S18. The proteins S1 and S20 could not be 
resolved on the 30S control. The intactness of the rRNA was con-
fi rmed by RNA electrophoresis. Controls containing the 21S parti-
cles were subjected to a reconstitution incubation in the presence of 
TP30 and checked for poly(Phe) synthesis in the presence of mature 
50S subunits. The results confi rmed that the 21S particles were 
authentic intermediates, which could be processed to active 30S 
subunits. 
 GTPase assay 
 The assay was performed in a 50-µl reaction volume under opti-
mized ion conditions (20 mM HEPES-KOH [pH 8.0 at 0°C], 4.5 mM 
Mg(acetate) 2 , 150 mM K(acetate), 2 mM spermidine, 0.05 mM sper-
mine, and 4 mM β-mercaptoethanol). The incubation mixture con-
tained 10 pmol of YqeH or NOA1, 2.5 nmol of [γ 32 P]GTP (20 dpm/
pmol), and the indicated amounts of rRNA, 21S particles, or ribo-
somal subunits. Samples were incubated either 1 h at 30°C or 6 h at 
20°C, and the reaction was stopped by the addition of 120 µl of 
0.5 M H 2 SO 4 and 1.5 mM NaH 2 PO 4 . The released γ-phosphate was 
extracted by mixing the samples with 30 µl of 200 mM MoNaO 4 and 
800 µl of water-saturated 2-butanol. Samples were vortexed for 
1 min followed by centrifugation at 16,000 ×  g for 10 min at 4°C. 
The radioactivity obtained in the butanol phase was measured in a 
Wallac 1409 Liquid Scintillation Counter . 
 All animal experimental procedures were approved by the local 
animal ethics commission, State Offi ce of Health and Welfare Berlin 
(LAGeSo). 
(+20 s/cycle). For detection of shorter products, elongation time was 
reduced to 8 min. 
 ATP assay 
 ATP levels were measured with the ATPlite Bioluminescence Assay 
kitSystem (Roche). Cells were trypsinized after a 36-h incubation 
time in culture medium with (4.5 g/l) or without glucose. The cells 
were washed once in PBS and resuspended in the kit’s dilution 
buffer. 
 Viability assay 
 Viability was measured with an alamarBlue assay according to sup-
plied protocol (Invitrogen ). Defi ned cell numbers were plated in 96-
well formats, and the resazurin substrate reduction was monitored in 
the cell culture medium by measuring the accumulation of the fl uo-
rescent resorufi n (excitation at 530 nm, emission at 590 nm). 
 Preparation of rRNA 
 16S rRNA and 23S+5S rRNA of  E. coli were prepared by phenol 
extraction followed by ethanol precipitation starting with purifi ed 
30S and 50S ribosomal subunits, respectively (Lietzke and Nierhaus, 
 1988 ). The genes coding for the mitochondrial 12S and 16S rRNA 
were amplifi ed from human mtDNA using the primers mt12S fw and 
mt12S rev or mt16S fw and mt16S rev, leading to the fusion of a T7 
promoter sequence at the 5′-end of the genes. PCR fragments were 
digested with  Hind III and  Eco RI and cloned into pSP65 cleaved 
with the same enzymes. Transcription of the genes was performed 
in vitro using T7 RiboMAX Express (Promega, Madison, WI) 
with the new constructed plasmids (linearized with  Eco RI) as tem-
plate. Transcribed RNA was purifi ed by gel fi ltration and ethanol 
precipitation. 
 Cloning, expression, and purifi cation of  B. subtilis YqeH and 
human NOA1 
 The gene coding for  B. subtilis YqeH was amplifi ed from genomic 
DNA by PCR and cloned into pET28a (Novagen, Merck KGaA, 
Darmstadt, Germany ) via  Nde I and  Xho I, leading to an N-terminal 
His-tag fusion. The correct sequence was confi rmed by sequenc-
ing. The gene was expressed in BL21(DE3) and the protein purifi ed 
via Ni-NTA agarose (Qiagen, Valencia, CA, according to the manu-
facture’s manual) followed by anion exchange chromatography 
(MonoQ, GE Healthcare, Piscataway, NJ). The protein was fi nally 
dialyzed against 20 mM HEPES·KOH (pH 8.0 at 0°C), 6 mM 
Mg(acetate) 2 , 150 mM K(acetate), and 4 mM β-mercaptoethanol. 
 Full-length cDNAs for human NOA (IRALp962E057Q2) was ob-
tained from the German Resource Center for Genome Research 
(RZPD, Berlin). The gene coding for Δ 25a.a.-hNOA1 protein 
(hNOA1 without mitochondria targeting sequence – 25 amino acids 
of N terminus) was amplifi ed by PCR and cloned into pGEX-6P 
(Amersham Pharmacia Biotech, Buckinghamshire, UK) via  Eco RI and 
 Xho I leading to an N-terminal GST-tag fusion. The gene was 
expressed in BL21-CodonPlus (DE3)-RP (Stratagene, Santa Clara, 
CA ), and the protein was purifi ed via Glutathione Sepharose 4B 
(Amersham Pharmacia Biotech, Piscataway, NJ) using PBS buffer pH 
6.2 supplemented with 1% Triton X-100, according to the manufac-
ture’s manual. The protein was fi nally dialyzed against 50 mM Tris, 
pH 7.0, at 4°C, 150 mM NaCl and concentrated using Centriprep 
YM-10 (Amicon, Bedford, MA ). 
 30S reconstitution and poly(Phe) synthesis 
 0.125 A 260 unit of 16S  E. coli rRNA equivalent to 9 pmol was incu-
bated with 0.05 equivalent units (e.u.) of total proteins of the 30S 
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